Publication

Note: Bold text indicates current and former members of our lab. * represents equal contributions. ** represents corresponding author(s).

2024

Park M, Kim JS, Park YA, Lee DH, Choi SA, Chang YK, Song TJ**, Gwak HS**, Yee J**. Association between insulin-associated gene polymorphisms and new-onset diabetes mellitus in statin-treated patients. Eur J Clin Invest. Accepted.
Oakes EG, Ellrodt J, Guan H, Yee J, Choi MY, Costenbader KH. Increased risk of adverse events among patients with vs. without systemic autoimmune rheumatic disease prescribed sodium-glucose cotransporter 2 inhibitors: a retrospective cohort study. Clin Rheumatol. doi:10.1007/s10067-024-07206-w. Epub ahead of print.
Yee J**, Feldman CH, Oakes EG, Ellrodt J, Guan H, Choi MY, Karlson EW, Costenbader KH. Cost-related Medication Behaviors for Patients with and without Systemic Autoimmune Rheumatic Diseases. Arthritis Care Res (Hoboken). doi: 10.1002/acr.25442. Epub ahead of print.
Choi SA, Kim JS, Park YA, Lee DH, Park M, Yee J, Chang Y, Song TJ, Gwak HS. Transporter genes and statin-induced hepatotoxicity. Cardiovasc Drugs Ther. doi: 10.1007/s10557-024-07580-2. Epub ahead of print.
Park YA, Park J, Yee J**, Gwak HS**. Effects of CYP3A5 genetic polymorphisms on the weight-adjusted trough concentration of sirolimus in renal transplant recipients: A systematic review and meta-analysis. Curr Pharm Des. 2024;30(39):3108-3115.doi: 10.2174/0113816128324199240730093415.
Oakes EG, Dillon E, Buhler KA, Guan H, Paudel M, Marks K, Adejoorin I, Yee J, Ellrodt J, Tedeschi S, Sparks J, Case SM, Hsu T, Solomon DH, Jonsson AH, Alexander RV, Rao DA, Choi MY, Costenbader KH. Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies. J Autoimmun. 2024;148:103299. doi: 10.1016/j.jaut.2024.103299.
Shim S, Kim JS, Yee J**, Gwak HS**. A risk-scoring system to predict dupilumab-associated ocular surface disease in patients with atopic dermatitis. Front Pharmacol. 2024;15:1425550. doi:10.3389/fphar.2024.1425550.
Song Y, Park YA, Lee DH, Yee J, Gwak HS. Sleep-related adverse events of smoking cessation drugs: A network meta-analysis of randomized controlled trials. Psychiatry Res. 2024;335:115874. doi: 10.1016/j.psychres.2024.115874.
Oakes EG, Ellrodt J, Yee J, Guan H, Kubzansky LD, Koenen KC, Costenbader KH. Posttraumatic stress disorder symptoms in systemic autoimmune rheumatic disease patients during the early COVID-19 pandemic. Int J Rheum Dis. 2024;27(1):e14974. doi: 10.1111/1756-185X.14974.

2023

Choi KH*, Yee J*, Song TJ, Park J, Gwak HS. Association between genetic polymorphisms in fibrinogen genes and bleeding risk in patients treated with direct oral anticoagulants. Ann Acad Med Singap. 2023;52(7):340-7. doi:10.47102/annals-acadmedsg.202328Copy.
Jang EJ, Kim JS, Choi SA, Yee J, Song TJ, Park J, Gwak HS. Construction of a risk scoring system using clinical factors and RYR2 polymorphisms for bleeding complications in patients on direct oral anticoagulants. Front Pharmacol. 2023;14:1290785. doi: 10.3389/fphar.2023.1290785.
Kim JY, Han JM, Yun B, Yee J, Gwak HS. Machine learning-based prediction of risk factors for abnormal glycemic control in diabetic cancer patients receiving nutrition support: a case-control study. Hormones (Athens). 2023;22(4):637-645. doi: 10.1007/s42000-023-00492-0.
Han JM, Jang EJ, Yee J, Song TJ, Kim DH, Park J, Gwak HS. Association between SLCO1B1 genetic polymorphisms and bleeding risk in patients treated with edoxaban. Sci Rep. 2023;13(1):15967. doi: 10.1038/s41598-023-43179-7.
Kim H, Song TJ, Yee J, Kim DH, Park J, Gwak HS. ABCG2 gene polymorphisms may affect the bleeding risk in patients on apixaban and rivaroxaban. Drug Des Devel Ther. 2023;17:2513-2522. doi: 10.2147/DDDT.S417096.
Kim JS, Lee S, Yee J, Park K, Jang EJ, Chang BC, Gwak HS. Novel gene polymorphisms for stable warfarin dose in a Korean population: genome-wide association study. Biomedicines. 2023;11(8):2308. doi: 10.3390/biomedicines11082308.
Kim JS, Shim S, Yee J, Choi KH, Gwak HS. Effects of CYP3A4*22 polymorphism on trough concentration of tacrolimus in kidney transplantation: a systematic review and meta-analysis. Front Pharmacol. 2023;14:1201083. doi: 10.3389/fphar.2023.1201083.
Kim JS, Kim JW, Yee J, Kim SJ, Chung JE, Gwak HS. Interactive associations between PPARγ and PPARGC1A and bisphosphonate-related osteonecrosis of the jaw in patients with osteoporosis. Pharmaceuticals (Basel). 2023;16(7):1035. doi: 10.3390/ph16071035.
Choi SY, Kim JW, Oh SH, Cheon S, Yee J, Kim SJ, Gwak HS, Chung JE. Prediction of medication-related osteonecrosis of the jaws using machine learning methods from estrogen receptor 1 polymorphisms and clinical information. Front Med (Lausanne). 2023;10:1140620. doi:10.3389/fmed.2023.1140620.
Jang EJ, Lee DH, Im SS, Yee J, Gwak HS. Correlation between PPARG Pro12Ala polymorphism and therapeutic responses to thiazolidinediones in patients with type 2 diabetes: a meta-analysis. Pharmaceutics. 2023;15(6):1778. doi: 10.3390/pharmaceutics15061778.

2022

Yoon HY, Song TJ, Yee J, Park J, Gwak HS. Association between genetic polymorphisms and bleeding in patients on direct oral anticoagulants. Pharmaceutics. 2022;14(9):1889. doi: 10.3390/pharmaceutics14091889.
Jang EJ, Kim YJ, Hwang HS, Yee J**, Gwak HS**. Associations of GNAS and RGS Gene polymorphisms with the risk of ritodrine-induced adverse events in Korean women with preterm labor: a cohort study. Pharmaceutics. 2022;14(6):1220. doi: 10.3390/pharmaceutics14061220.
Kim JY*, Yee J*, Yoon HY, Han JM, Gwak HS. Risk factors for vancomycin-associated acute kidney injury: a systematic review and meta-analysis. Br J Clin Pharmacol. 2022;88(9):3977-3989. doi: 10.1111/bcp.15429.
Yoon HY, Lee H, Yee J**, Gwak HS**. Global research trends of gender-related artificial intelligence in medicine between 2001-2020: A bibliometric study. Front Med (Lausanne). 2022;9:868040. doi: 10.3389/fmed.2022.868040.
Kim H, Bae S, Yoon HY, Yee J**, Gwak HS**. Association of SLC47A1 gene variant with responses to metformin monotherapy in drug-naïve patients with type 2 diabetes: A systematic review and meta-analysis. J Clin Endocrinol Metab. 2022;107(9):2684-2690. doi: 10.1210/clinem/dgac333.
Lee Y, Jang EJ, Yoon HY, Yee J, Gwak HS. Effect of ITPA polymorphism on adverse drug reactions of 6-mercaptopurine in pediatric patients with acute lymphoblastic leukemia: a systematic review and meta-analysis. Pharmaceuticals. 2022;15:416. doi: 10.3390/ph15040416.
Park YA, Park KH, Yoon HY, Yee J**, Gwak HS**. Effects of CYP2D6 genotypes on Plasmodium vivax recurrence after primaquine treatment: A meta-analysis. Travel Med Infect Dis. 2022;48:102333. doi: 10.1016/j.tmaid.2022.102333.
Han JM, Yee J, Cho S, Kim MK, Moon JY, Jung D, Kim JS, Gwak HS. A risk scoring system utilizing machine learning methods for hepatotoxicity prediction one year after the initiation of tyrosine kinase inhibitors. Front Oncol. 2022;12:790343. doi: 10.3389/fonc.2022.790343.
Song Y, Lim HH, Yee J, Yoon HY, Gwak HS. The association between ABCG2 421C>A (rs2231142) polymorphism and rosuvastatin pharmacokinetics: a systematic review and meta-analysis. Pharmaceutics. 2022;14(3):501. doi: 10.3390/pharmaceutics14030501.
Kim JY, Kim KY, Yee J**, Gwak HS**. Risk scoring system for vancomycin-associated acute kidney injury. Front Pharmacol. 2022;13:815188. doi: 10.3389/fphar.2022.815188.
Song G, Yoon HY, Yee J, Kim MG, Gwak HS. Antihypertensive drug use and psoriasis: a systematic review, meta- and network meta-analysis. Br J Clin Pharmacol. 2022;88(3):933-941. doi: 10.1111/bcp.15060.
Lee DH, Lee H, Yoon HY, Yee J**, Gwak HS**. Association of P450 oxidoreductase gene polymorphism with tacrolimus pharmacokinetics in renal transplant recipients: a systematic review and meta-analysis. Pharmaceutics. 2022;14(2):261. doi: 10.3390/pharmaceutics14020261.
Yee J*, Song TJ*, Yoon HY, Park J, Gwak HS. Genetic factors of renin-angiotensin system associated with major bleeding for patients treated with direct oral anticoagulants. Pharmaceutics. 2022;14(2):231. doi: 10.3390/pharmaceutics14020231.

2021

Yee J, Han HW, Gwak HS. Proton pump inhibitor use and hearing loss in patients with type 2 diabetes: evidence from a hospital-based case-control study and a population-based cohort study. Br J Clin Pharmacol. 2022;88(6):2738-2746. doi: 10.1111/bcp.15210.
Yoo HJ, Yoon HY, Yee J**, Gwak HS**. Effects of ephedrine-containing products on weight loss and lipid profiles: a systematic review and meta-analysis of randomized controlled trials. Pharmaceuticals (Basel). 2021;14(11):1198. doi: 10.3390/ph14111198.
Han HW*, Yee J*, Park YH, Gwak HS. Association between statin use and sensorineural hearing loss in type 2 diabetic patients: a hospital-based study. Pharmaceuticals (Basel). 2021:25;14(11):1076. doi: 10.3390/ph14111076.
Lee N, Yoon HY, Park JY, Kim YJ, Hwang HS, Yee J, Gwak HS. Association between ADCY9 gene polymorphisms and ritodrine treatment outcomes in patients with preterm labor. Pharmaceutics. 2021;13(10):1653. doi: 10.3390/pharmaceutics13101653.
Kim K*, Yee J*, Chung JE, Kim HJ, Han JM, Kim JH, Lee KE, Gwak HS. Smartphone addiction and anxiety in adolescents - a cross-sectional study. Am J Health Behav. 2021;45(5):895-901. doi: 10.5993/AJHB.45.5.9.
Shim SY, Yoon HY, Yee J, Han JM, Gwak HS. Association between ABCA1 gene polymorphisms and plasma lipid concentration: a systematic review and meta-analysis. J Pers Med. 2021;11(9):883. doi: 10.3390/jpm11090883.
Song G, Chung JE, Yee J, Lee KE, Park K, Gwak HS. Effects of SLCO1B1 and SLCO1B3 genetic polymorphisms on valsartan pharmacokinetics in healthy Korean volunteers. J Pers Med. 2021;11(9):862. doi: 10.3390/jpm11090862.
Kim JH*, Yee J*, Chang BC, Gwak HS. Gene polymorphisms of the renin-angiotensin system and bleeding complications of warfarin: genetic-based machine learning models. Pharmaceuticals (Basel). 2021;14(8):824. doi: 10.3390/ph14080824.
Yee J*, Kim H*, Heo Y, Yoon HY, Song G, Gwak HS. Association between CYP3A5 polymorphism and statin-induced adverse events: a systemic review and meta-analysis. J Pers Med. 2021 Jul 19;11(7):677. doi: 10.3390/jpm11070677.
Kim JY*, Yee J*, Park TI, Shin SY, Ha MH, Gwak HS. Risk scoring system of mortality and prediction model of hospital stay for critically ill patients receiving parenteral nutrition. Healthcare. 2021;9:853. doi: 10.3390/healthcare9070853.
Park YA, Song YB, Yee J, Yoon HY, Gwak HS. Influence of CYP2C9 genetic polymorphisms on the pharmacokinetics of losartan and its active metabolite E-3174: a systematic review and meta-analysis. J Pers Med. 2021;11(7):617. doi: 10.3390/jpm11070617.
Kim W*, Yee J*, Chang BC, Chung JE, Lee KE, Gwak HS. TGF-β1 polymorphism increases the risk of bleeding complications in patients on oral anticoagulant after cardiac valve replacement. Heart Vessels . 2021;36(12):1885-1891.doi: 10.1007/s00380-021-01867-2.
Kim JW, Yee J, Oh SH, Kim SH, Kim SJ, Chung JE, Gwak HS. Machine learning approaches for predicting bisphosphonate-related osteonecrosis in women with osteoporosis using VEGFA gene polymorphisms. J Pers Med. 2021;11(6):541. doi: 10.3390/jpm11060541.
Song G, Kim JY, Yoon HY, Yee J, Gwak HS. A systematic review and meta-analysis of angiotensin-converting enzyme inhibitor use and psoriasis incidence. Sci Rep. 2021;11(1):10037. doi: 10.1038/s41598-021-89490-z.
Yoon HY, Lee MH, Song Y, Yee J, Song G, Gwak HS. ABCA1 69C>T polymorphism and the risk of type 2 diabetes mellitus: a systematic review and updated meta-analysis. Front Endocrinol (Lausanne). 2021;12:639524. doi: 10.3389/fendo.2021.639524.
Yee J*, Heo Y*, Kim H, Yoon HY, Song G, Gwak HS. Association between the CYP2C9 genotype and hypoglycemia among patients with type 2 diabetes receiving sulfonylurea treatment: a meta-analysis. Clin Ther. 2021;43(5):836-843.e4. doi: 10.1016/j.clinthera.2021.03.008.
Yoo HJ, Han JM, Kim K, Song G, Yee J, Chung JE, Lee KE, Gwak HS. Association between attention deficit hyperactivity disorder and aggression subscales in adolescents. Brain Behav. 2021;11(3):e02030. doi: 10.1002/brb3.2030.
Yee J*, Cho YA*, Yoo HJ, Yun H, Gwak HS. Short-term exposure to air pollution and hospital admission for pneumonia: a systematic review and meta-analysis. Environ Health. 2021;20(1):6. doi: 10.1186/s12940-020-00687-7.

2020

Yee J*, Kim W*, Han JM, Yoon HY, Lee N, Lee KE, Gwak HS. Clinical manifestations and perinatal outcomes of pregnant women with COVID-19: a systematic review and meta-analysis. Sci Rep. 2020;10(1):18126. doi: 10.1038/s41598-020-75096-4.
Yoon HY, Cho YA, Yee J**, Gwak HS**. Effects of CYP2B6 polymorphisms on plasma nevirapine concentrations: a systematic review and meta-analysis. Sci Rep. 2020;10(1):17390. doi: 10.1038/s41598-020-74506-x.
Kang S*, Yee J*, Kim JY, Han HW, Kang SO, Lee KE, Gwak HS. Factors associated with voriconazole concentration in pediatric patients. Ther Drug Monit. 2020;42(6):866-871. doi: 10.1097/FTD.0000000000000804.
Han JM, Han HW, Yee J, Kim MK, Moon JY, Cho S, Jung D, Cho YS, Seo I, Kim JY, Gwak HS. Factors affecting high-grade hepatotoxicity of tyrosine kinase inhibitors in cancer patients: a multi-center observational study. Eur J Clin Pharmacol. 2020;76(8):1183-1191. doi: 10.1007/s00228-020-02897-x.
Chung EK*, Yee J*, Kim JY, Gwak HS. Low cyclosporine concentrations in children and time to acute graft versus host disease. BMC Pediatr. 2020;20(1):206. doi: 10.1186/s12887-020-02125-6.
Yoon HY, Ahn MH, Yee J, Lee N, Han JM, Gwak HS. Influence of CYP2C9 and CYP2A6 on plasma concentrations of valproic acid: a meta-analysis. Eur J Clin Pharmacol. 2020;76(8):1053-1058. doi: 10.1007/s00228-020-02872-6.
Yoon HY, Park JY, Yee J, Hwang HS, Chung JE, Lee KE, Kim YJ, Gwak HS. Effects of KCNMB2 gene polymorphisms on ritodrine therapy outcomes in women with preterm labor. Pharmacogenet Genomics. 2020;30(6):124-130. doi: 10.1097/FPC.0000000000000404.
Lee KE*, Yee J*, Lee GY, Chung JE, Seong JM, Chang BC, Gwak HS. Genotype-guided warfarin dosing may benefit patients with mechanical aortic valve replacements: randomized controlled study. Sci Rep. 2020;10(1):6988. doi: 10.1038/s41598-020-63985-7.
Han JM, Yee J, Chung JE, Lee KE, Park K, Gwak HS. Effects of cytochrome P450 oxidoreductase genotypes on the pharmacokinetics of amlodipine in healthy Korean subjects. Mol Genet Genomic Med. 2020;8(5):e1201. doi: 10.1002/mgg3.1201.
Yee J*, Kim SM*, Han JM, Lee N, Yoon HY, Gwak HS. The association between NAT2 acetylator status and adverse drug reactions of sulfasalazine: a systematic review and meta-analysis. Sci Rep. 2020;10(1):3658. doi: 10.1038/s41598-020-60467-8.
Kim JH, Kim JY, Lee N, Yee J, Gwak HS. The impact of drug interactions on adverse effects of oral oxycodone in male geriatric patients. J Clin Pharm Ther. 2020;45(5):976-982. doi: 10.1111/jcpt.13113.
Kim K*, Yee J*, Kim JH, Chung JE, Lee KE, Song G, Han JM, Gwak HS. Health behaviors associated with aggression in Korean adolescents: data from 2 cross-sectional studies. Am J Health Behav. 2020;44(2):271-282. doi: 10.5993/AJHB.44.2.14.
Sung JW, Yun HY, Park S, Kim YJ, Yee J, Lee KE, Song B, Chung JE, Gwak HS. Population pharmacokinetics of sulindac and genetic polymorphisms of FMO3 and AOX1 in women with preterm labor. Pharm Res. 2020;37(3):44. doi: 10.1007/s11095-020-2765-6.
Chung JE*, Yee J*, Hwang HS, Park JY, Lee KE, Kim YJ, Gwak HS. Influence of GRK5 gene polymorphisms on ritodrine efficacy and adverse drug events in preterm labor treatment. Sci Rep. 2020;10(1):1351. doi: 10.1038/s41598-020-58348-1.
Lee N, Park SM, Yee J, Yoon HY, Han JM, Gwak HS. Association between glutathione-S-transferase gene polymorphisms and responses to tyrosine kinase inhibitor treatment in patients with chronic myeloid leukemia: a meta-analysis. Target Oncol. 2020;15(1):47-54. doi: 10.1007/s11523-020-00696-z.
Yang JA, Lee KE, Park JH, Yee J, Kim JY, Gwak HS. Effects of citrulline supplementation on body weight in patients with hepatobiliary pancreatic surgery. Nutr Clin Pract. 2020;35(2):323-330. doi: 10.1002/ncp.10395.
Han JM, Yee J, Cho YS, Gwak HS. Factors influencing imatinib-induced hepatotoxicity. Cancer Res Treat. 2020;52(1):181-188. doi: 10.4143/crt.2019.131.
Jeon MS, Jeong YM, Yee J, Lee E, Kim KI, Lee BK, Rhie SJ, Chung JE, Gwak HS. Association of pre-operative medication use with unplanned 30-day hospital readmission after surgery in oncology patients receiving comprehensive geriatric assessment. Am J Surg. 2020;219(6):963-968. doi: 10.1016/j.amjsurg.2019.06.020.
Jeong YM, Chung JE, Choi KS, Jeon MS, Yee J, Lee E, Kim KI, Lee BK, Gwak HS. Association between preoperative use of antithrombotic medications and intraoperative transfusion in older patients undergoing cancer surgery. Asian J Surg. 2020;43(5):585-592. doi: 10.1016/j.asjsur.2019.06.005.

~2019

Yee J*, Kim W*, Chang BC, Chung JE, Lee KE, Gwak HS. Effects of Polymorphisms in Myc-related genes on bleeding complications in patients with stable warfarin responses. Cardiovasc Ther. 2019;2019:1813747. doi: 10.1155/2019/1813747.
Park EH, Kim JH, Yee J, Chung JE, Seong JM, La HO, Gwak HS. Comparisons of doxycycline solution with talc slurry for chemical pleurodesis and risk factors for recurrence in South Korean patients with spontaneous pneumothorax. Eur J Hosp Pharm. 2019;26(5):275-279. doi: 10.1136/ejhpharm-2017-001465.
Kim W*, Yee J*, Chang BC, Chung JE, Lee KE, Gwak HS. Association between HNF4A mutations and bleeding complications in patients with stable international normalized ratio. Pharmacogenet Genomics. 2019;29(8):200-206. doi: 10.1097/FPC.0000000000000384.
Yee J, Hwang HS, Chung JE, Park JY, Lee KE, Kim YJ, Gwak HS. Effects of PDE4 gene polymorphisms on efficacy and adverse drug events of ritodrine therapy in preterm labor patients: a prospective observational study. Eur J Clin Pharmacol. 2019;75(10):1379-1386. doi: 10.1007/s00228-019-02719-9.
Yee J*, Kim W*, Chang BC, Chung JE, Lee KE, Gwak HS. Genetic variations in the transcription factors GATA4 and GATA6 and bleeding complications in patients receiving warfarin therapy. Drug Des Devel Ther. 2019;13:1717-1727. doi: 10.2147/DDDT.S198018.
Yee J*, Kim W*, Chang BC, Chung JE, Lee KE, Gwak HS. APOB gene polymorphisms may affect the risk of minor or minimal bleeding complications in patients on warfarin maintaining therapeutic INR. Eur J Hum Genet. 2019;27(10):1542-1549. doi: 10.1038/s41431-019-0450-1.
Yee J*, Kim W*, Chang BC, Chung JE, Lee KE, Gwak HS. Association between VEGFA gene polymorphisms and bleeding complications in patients maintaining therapeutic international normalized ratio. Pharmacogenomics. 2019;20(9):659-667. doi: 10.2217/pgs-2019-0005.
Chung JE, Song G, Kim K, Yee J, Kim JH, Lee KE, Gwak HS. Association between anxiety and aggression in adolescents: a cross-sectional study. BMC Pediatr. 2019;19(1):115. doi: 10.1186/s12887-019-1479-6.
Lee M, Yee J, Kim JY, Kim JY, An SH, Lee KE, Gwak HS. Risk factors for neutropenia and febrile neutropenia following prophylactic pegfilgrastim. Asia Pac J Clin Oncol. 2019;15(4):231-237. doi: 10.1111/ajco.13152.
Seong JM, Yee J, Gwak HS. Dipeptidyl peptidase-4 inhibitors lower the risk of autoimmune disease in patients with type 2 diabetes mellitus: A nationwide population-based cohort study. Br J Clin Pharmacol. 2019;85(8):1719-1727. doi: 10.1111/bcp.13955.
Moon JY, Lee Y, Han JM, Lee MH, Yee J, Song MK, Kim YJ, Gwak HS. Effects of pharmacist interventions on reducing prescribing errors of investigational drugs in oncology clinical trials. J Oncol Pharm Pract. 2020;26(1):29-35. doi: 10.1177/1078155219834723.
Kim JY, Kim JH, Yee J, Song SJ, Gwak HS. Risk factors of opioid-induced adverse reactions in elderly male outpatients of Korea Veterans Hospital. BMC Geriatr. 2018;18(1):293. doi: 10.1186/s12877-018-0990-1.
Jung D, Han JM, Yee J, Kim JY, Gwak HS. Factors affecting crizotinib-induced hepatotoxicity in non-small cell lung cancer patients. Med Oncol. 2018;35(12):154. doi: 10.1007/s12032-018-1213-5.
Kim MK*, Yee J*, Cho YS, Jang HW, Han JM, Gwak HS. Risk factors for erlotinib-induced hepatotoxicity: a retrospective follow-up study. BMC Cancer. 2018;18(1):988. doi: 10.1186/s12885-018-4891-7.
Yi BR, Kim HJ, Park HS, Cho YJ, Kim JY, Yee J, Chung JE, Kim JH, Lee KE, Gwak HS. Association between MKRN3 and LIN28B polymorphisms and precocious puberty. BMC Genet. 2018;19(1):47. doi: 10.1186/s12863-018-0658-z.
Chung JE, Choi SA, Kim KT, Yee J, Kim JH, Seong JW, Seong JM, Kim JY, Lee KE, Gwak HS. Smartphone addiction risk and daytime sleepiness in Korean adolescents. J Paediatr Child Health. 2018;54(7):800-806. doi: 10.1111/jpc.13901.
Park YH, Cho S, Yee J, Kim JY, Rhie SJ, Gwak HS. Factors affecting time to reach and recover from gefitinib-induced hepatotoxicity. Anticancer Drugs. 2018;29(5):471-476. doi: 10.1097/CAD.0000000000000622.
Choi KS, Jeong YM, Lee E, Kim KI, Yee J, Lee BK, Chung JE, Rhie SJ, Gwak HS. Association of pre-operative medication use with post-surgery mortality and morbidity in oncology patients receiving comprehensive geriatric assessment. Aging Clin Exp Res. 2018;30(10):1177-1185. doi: 10.1007/s40520-018-0904-2.
Cho S, Yee J, Kim JY, Jeong Rhie S, Gwak HS. Effects of concomitant medication use on gefitinib-induced hepatotoxicity. J Clin Pharmacol. 2018;58(2):263-268. doi: 10.1002/jcph.1010.
Lee MH, Yee J, Kim YJ, Moon JY, Kim JH, Rhie SJ, Gwak HS. Factors for time to trastuzumab-induced cardiotoxicity in breast cancer patients. Med Oncol. 2017;34(12):199. doi: 10.1007/s12032-017-1041-z.
Chung JE, Choi SA, Hwang HS, Park JY, Lee KE, Yee J, Kim YJ, Gwak HS. Association between ß2-adrenergic receptor gene polymorphisms and adverse events of ritodrine in the treatment of preterm labor: a prospective observational study. BMC Genet. 2017;18(1):96. doi: 10.1186/s12863-017-0565-8.
Baek MY, Hwang HS, Park JY, Chung JE, Lee KE, Lee GY, Seong JW, Yee J, Kim YJ, Gwak HS. Association between CACNA1C gene polymorphisms and ritodrine-induced adverse events in preterm labor patients. Eur J Clin Pharmacol. 2017;73(7):837-842. doi: 10.1007/s00228-017-2222-6.